USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

USANA Health Sciences addresses challenges, eyes growth through cost management

USANA Health Sciences navigated a challenging operating environment by focusing on cost management, product demand trends, and growth strategies. Despite facing headwinds in China and Southeast Asia, the company remains resilient and poised for opportunities in new markets and acquisitions.

USANA Health Sciences reports solid Q1 results amid global challenges

USANA Health Sciences delivered strong Q1 results amidst global challenges, driven by robust demand for health products.
Strategic leadership transition and focus on cost management position the company for sustained growth and operational efficiency.
Opportunities in China market, new market launches, and enhanced customer engagement strategies offer avenues for future expansion.

USANA Health Sciences exceeds Q2 expectations, eyes India expansion

USANA Health Sciences delivered strong Q2 results with a focus on sustainable growth strategies and expansion into new markets. Challenges include tough year-over-year comparisons and cash flow impact from accrued liabilities.

USANA Health Sciences addresses challenges, eyes India expansion for growth

USANA Health Sciences navigated challenges in Q3 2023 with a focus on addressing operational hurdles and driving growth through strategic initiatives. The company's restructuring and expansion into India signal a commitment to long-term success and capitalizing on emerging opportunities.

USANA Health Sciences exceeds Q4 expectations, eyes global growth

USANA Health Sciences delivered strong performance in Q4 2023, driven by growth in Greater China and a solid financial position. While facing challenges such as currency fluctuations and market-specific issues, the company is well-positioned to capitalize on opportunities through strategic initiatives and market tailoring. By focusing on sustainable growth and innovation, USANA aims to further strengthen its market presence and drive profitability.

USANA Health Sciences reports mixed Q1 results, eyes growth strategies

USANA Health Sciences faced mixed results in Q1 2024, with Mainland China driving growth while other markets struggled. The company is addressing challenges through market-specific incentives and focusing on future strategies like product development and localization.

USANA Health Sciences adapts to market challenges with strategic focus

USANA Health Sciences navigated macroeconomic challenges by implementing strategic initiatives and restructuring its commercial team.
The company's focus on product innovation, market expansion into India, and leadership additions signal a commitment to sustainable success.
While facing challenges in market conditions, USANA aims to leverage opportunities like M&A activities and accelerated product development for growth.

USANA Health Sciences adapts strategies to drive growth amid challenges

USANA Health Sciences faced challenges in Q3 with lower-than-expected net sales, particularly in China, but is implementing strategies to boost performance.
The company's strengths in product innovation, streamlined development processes, and strong product lineup position it well for future growth.
Addressing challenges such as decreased average spend and revised guidance presents opportunities for USANA to enhance revenue and market presence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

USANA Health Sciences, Inc.'s (USNA) CEO Kevin Guest on Q4 2021 Results - Earnings Call Transcript

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its full year and fiscal fourth quarter ended January 1, 2022. Key Financial & Operating Highlights Fiscal year 2021 net sales grew 5% to $1.186 billion. Reported fiscal year 2021 diluted EPS totaled $5.73. Fourth quarter net sales reached $267 million and diluted EPS were $1.03. Company provides initial 2022 net sales guidance of $1.125 to $1.225 billion and initial diluted EPS g

USANA Health Sciences Reports Fiscal Year and Fourth Quarter 2021 Results

Bestselling Author, CEO Kevin Guest Shares Insights from Global Leadership SALT LAKE CITY, Feb. 7, 2022 /PRNewswire/ -- Teams working together with more love and harmony increases productivity and happiness, according to one author and global CEO. "Because February is the month we celebrate love, it's the perfect time to increase our respect and harmony in all aspects of life," said Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), and author of All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony.

Increase Harmony in Month of Love for Productivity

SALT LAKE CITY, Feb. 3, 2022 /PRNewswire/ -- USANA's international markets have started off the new year with two major awards. USANA Korea was presented the 'family-friendly company' certification selected by the Ministry of Gender Equality and Family, while Citta Bella Magazine awarded USANA Malaysia for its Celavive Vitalizing Serum.

USANA's Malaysia and Korea markets start 2022 with major honors

USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: USANA Health Sciences (USNA) Q4 Earnings Expected to Decline

SALT LAKE CITY, Feb. 1, 2022 /PRNewswire/ -- USANA released its first sustainability report in 2021 to establish a company baseline and guide upcoming goals and future projects. Over the last three decades, USANA has invested in its people, products, and the planet, but the company recognized there was more work to do.

People, Products, Planet: USANA's 2021 Sustainability Efforts

Bestselling Author, CEO Kevin Guest Shares Insights from Global Leadership SALT LAKE CITY, Jan. 11, 2022 /PRNewswire/ -- National 'Take the Stairs Day' Jan. 12 can lift workers in three ways beyond physical health. So says bestselling author who motivates audiences around the world to reach their fullest potential.

3 Surprising Benefits of National Stairs Day

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter and FY 2021 results will be released after the close of market on Tuesday, February 8, 2022. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts

USANA Schedules Fourth Quarter and FY 2021 Earnings Release and Conference Call

Bestselling Author, CEO Kevin Guest Shares Insights from Global Leadership SALT LAKE CITY , Dec. 14, 2021 /PRNewswire/ -- As the pandemic lingers, professionals are urged to take four actions to enhance their careers in 2022. "In my role, I see professionals serious about their progress master four key practices," said Kevin Guest, chairman and CEO of USANA Health Sciences (NYSE: USNA), a billion-dollar company operating in 24 countries.

4 Ways to Enhance Career in 2022

SALT LAKE CITY, Nov. 24, 2021 /PRNewswire/ -- As USANA, the Cellular Nutrition Company, looks to its 30th anniversary next spring, it continues to showcase and build its elite and diverse athletic partnerships. For more than two decades, USANA has provided high-quality, NSF-tested nutritional products to more professional and Olympic athletes than any other nutritional supplement company in the world.

USANA Assists Philippine Basketball Association As Nutritional Partner

SALT LAKE CITY, Nov. 22, 2021 /PRNewswire/ -- During National Gratitude Month and Thanksgiving week, five ways to express gratitude can turn negative situations into more fulfillment, greater success and brighter results, said a bestselling author and international speaker. "Implementing these five steps gets a person out of a rut and provides practical tools to use no matter what comes at them," said Kevin Guest, Chairman and CEO of USANA Health Sciences (NYSE: USNA).

Use Power of Gratitude to Overcome Challenges

SALT LAKE CITY, Nov. 17, 2021 /PRNewswire/ -- USANA, a leader in cellular nutrition, is proud to announce three major awards won this past month. During the 2021 Direct Selling Association (DSA) Engage Conference, USANA received the Product Innovation award for its Mood and Relaxation Products, and the Vision for Tomorrow award for its charity, USANA Kids Eat.

USANA honored with three prestigious awards

SALT LAKE CITY, Nov. 1, 2021 /PRNewswire/ -- For Job Action Day Nov. 1, one international leader cites five items to stay relevant to bosses for career improvement during the pandemic. Established on the first Monday in Nov. 2008, Job Action Day was intended to empower and inspire hard workers who dreamed of achieving more.

Job Action Day: Bestselling Author Shares Five Points to Improve Career

Q3 results were mixed. We see stock buying opportunity with 35% upside. USANA has a 47% market presence in rapidly-growing China.

USANA: Q3 Mixed Results, We See 35% Upside, 15% 10-Year EPS CAGR

USANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q3 2021 Results - Earnings Call Transcript

USANA Health (USNA) delivered earnings and revenue surprises of 4.62% and 2.10%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

USANA Health Sciences (USNA) Q3 Earnings and Revenues Surpass Estimates

Usana Health Sciences (NYSE:USNA) reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:17 PM. Here's what investors need to know about the announcement.

Usana Health Sciences: Q3 Earnings Insights

SALT LAKE CITY, Oct. 18, 2021 /PRNewswire/ -- USANA, a leader in cellular nutrition, proudly announces that its Coenzyme Q10 (CoQ10) supplement — CoQuinone 30 — has received the prestigious seal of approval for purity and label accuracy from third-party tester ConsumerLab.com. CoQuinone 30 has received a seal of approval each time the product has been tested by ConsumerLab.com.

USANA CoQ10 Supplement Earns Another Seal of Approval for Purity

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced the appointment of Xia Ding to the company's board of directors effective October 11, 2021. Ms. Ding currently serves as Vice President of e-commerce Asia Pacific and Latin America at Nike and is well-regarded as an e-commerce and digital business leader. She has served in various management roles at several global online and omnichannel retailers, including Nike, JD.com and Hanesbrands. With the addition

Xia Ding Named to USANA Health Sciences' Board of Directors

SALT LAKE CITY, Oct. 10, 2021 /PRNewswire/ -- On World Mental Health Day Sunday, Oct. 10, six key actions can help provide balance during the ongoing pandemic. Bestselling author and international speaker Kevin Guest is urging everyone to reset during the pandemic with mindful steps that can make a difference.

World Mental Health Day; Bestselling Author/CEO Urges Self-Care for Pandemic Relief

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2021 results will be released after the close of market on Tuesday, October 26, 2021. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's website (http://ir.usana.com) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and inst

USANA Schedules Third Quarter 2021 Earnings Release and Conference Call

USANA had record second-quarter results with +42% EPS growth on +30% sales.

USANA: +42% EPS Growth, Upside Of 37%, Rapidly Growing In China Markets

Allstate

Credit Acceptance

LaZBoy

According to the Buffett-Munger Screener, one of several predefined screens available to GuruFocus Premium members, five stocks with good business fundamentals and are trading at attractive GF Values are Berkshire Hathaway Inc. ( BRK.A , Financial)( BRK.B , Financial), Usana Health Sciences Inc. ( USNA , Financial), La-Z-Boy Inc. ( LZB , Financial), Credit Acceptance Corp. ( CACC , Financial) and Allstate Corp. ( ALL , Financial).

5 Buffett-Munger Stocks Trading at Attractive GF Values

SALT LAKE CITY, Sept. 22, 2021 /PRNewswire/ -- Traditional Chinese Medicine (TCM) natural remedies have thrived in the East for thousands of years.

Yin Yang You, a global collaboration 5,000 years in the making

Edwards Lifesciences

Graco

Lululemon Athletica

Masimo

According to the “Good Companies Screen,” one of several Premium screens under the All-in-One Screener, five stocks with high financial strength and profitability are Edwards Lifesciences Corp. ( EW , Financial), Lululemon Athletica Inc. ( LULU , Financial), Masimo Corp. ( MASI , Financial), Graco Inc. ( GGG , Financial) and Usana Health Sciences Inc. ( USNA , Financial).

News for USANA Health Sciences Stock (USNA)